Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-25 @ 2:16 AM
NCT ID:
NCT06595160
Eligibility Criteria:
Inclusion Criteria:
* \* Age ≥ 18 years with signed informed consent form
* Patients must have a histological diagnosis of PDAC
* Resectable or borderline resectable PDAC on imaging
Exclusion Criteria:
* \* Patients with locally advanced and metastatic stage IV PDAC
* Patients who have already received or completed neoadjuvant chemotherapy for PDAC
* Patients with active malignancy receiving systemic therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06595160
Study Brief:
Protocol Section:
NCT06595160